Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NeurAxis, Inc. (NRXS – Research Report), Argenx Se (ARGX – Research Report) and Teladoc (TDOC – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NeurAxis, Inc. (NRXS)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on NeurAxis, Inc. today. The company’s shares closed last Tuesday at $6.97.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of
NeurAxis, Inc. has an analyst consensus of Moderate Buy.
See today’s best-performing stocks on TipRanks >>
Argenx Se (ARGX)
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Argenx Se. The company’s shares closed last Tuesday at $709.76.
According to TipRanks.com, Ahmad is a 2-star analyst with an average return of
Currently, the analyst consensus on Argenx Se is a Strong Buy with an average price target of $1034.50, implying a 45.3% upside from current levels. In a report issued on March 2, H.C. Wainwright also maintained a Buy rating on the stock with a $940.00 price target.
Teladoc (TDOC)
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Teladoc today and set a price target of $8.25. The company’s shares closed last Tuesday at $5.60.
According to TipRanks.com, Lutz is a 5-star analyst with an average return of
Currently, the analyst consensus on Teladoc is a Moderate Buy with an average price target of $7.28, representing a 33.8% upside. In a report issued on March 10, Deutsche Bank also upgraded the stock to Buy with a $11.00 price target.
